MAXHEALTH · Healthcare · Medical Care Facilities
Composite scorecard: 56/100 — Quality 61 · Valuation 31 · Growth 100 · Momentum 16
| Share price | ₹1,102.40 |
| Market cap | ₹1.06 lakh Cr |
| P/E ratio | 75.2 |
| P/B ratio | 10.6 |
| ROE | 26.3% |
| ROCE | 11.6% |
| Dividend yield | 0.14% |
| Book value | ₹102.71 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹8,373 Cr | ₹1,442 Cr | 27.0% |
| 2025 | ₹7,028 Cr | ₹1,076 Cr | 26.0% |
| 2024 | ₹5,406 Cr | ₹1,058 Cr | 28.0% |
| 2023 | ₹4,563 Cr | ₹1,104 Cr | 27.0% |
| 2022 | ₹3,937 Cr | ₹605 Cr | 24.0% |
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic s